Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Portola Pharma (PTLA)

Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Portola Pharma 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 USA

www.portola.com P: 650-246-7000

Description:

Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 1,415,067
Shares Outstanding, K 78,484
Annual Sales, $ 116,640 K
Annual Net Income, $ -290,660 K
Last Quarter Sales, $ 26,390 K
Last Quarter Net Income, $ -68,770 K
60-Month Beta 2.32
% of Insider Shareholders 2.20%
% of Institutional Shareholders 98.68%
Float, K 76,757
% Float 97.80%

Growth:

1-Year Return -32.47%
3-Year Return -69.17%
5-Year Return -61.18%
5-Year Revenue Growth 1,111.21%
5-Year Earnings Growth -27.27%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.88 on 05/11/20
Latest Earnings Date 08/05/20
Earnings Per Share ttm -3.72
EPS Growth vs. Prev Qtr 29.03%
EPS Growth vs. Prev Year 13.73%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PTLA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -267.85%
Return-on-Assets % -54.66%
Profit Margin % -249.19%
Debt/Equity 4.77
Price/Sales 12.10
Price/Cash Flow N/A
Price/Book 19.65
Book Value/Share 0.92
Interest Coverage -8.36
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar